– First to offer suite of tests in easy to access format for children with developmental disabilities – SAN FRANCISCO, April 4, 2022 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics ...
RESEARCH TRIANGLE PARK – Invitae, a California-based medical genetics company that will soon open a new laboratory and production facility in Morrisville, has commercially launched a new testing ...
Invitae is boosting its neurology and cardiology diagnostic test offerings. The San Francisco-based company will be adding 11 panels for heritable diseases and will update 17 existing neurology panels ...